To identify the regions of recurrent copy number abnormality in osteosarcoma and their effect on gene expression, we performed an integrated genome-wide high-resolution array CGH (aCGH) and gene expression profiling analysis on 40 human OS tissues and 12 OS cell lines. This analysis identified several recurrent chromosome regions that contain genes that show a gene dosage effect on gene expression. A further search, performed on those genes that were over-expressed and localized in the frequently amplified chromosomal regions, greatly reduced the number of candidate genes while their characterization using gene ontology (GO) analysis suggests the importance of the deregulation of the G1-to-S phase in the development of the disease. We also ...
Introduction: OS, a common Li-Fraumeni syndrome (LFS)-associated neoplasm, is a common bone malignan...
BACKGROUND Osteosarcoma is a rare but highly malignant cancer of the bone. As a consequence, the nu...
AbstractIdentification of target genes for genetic rearrangements in prostate cancer and the impact ...
Little is known about the genomic alterations underlying osteosarcoma. We performed a genomewide hig...
High-grade osteosarcoma is a tumor with a complex genomic profile, occurring primarily in adolescent...
Osteosarcoma is a primary malignancy of bone that affects children and adults. Here, we present the ...
Osteosarcoma is an aggressive bone tumor that preferentially develops in adolescents. The tumor is c...
BACKGROUND: Osteosarcomas are the most common non-haematological primary malignant tumours of bone, ...
. These authors contributed equally to this work. Osteosarcoma is an aggressive bone tumor that pref...
<div><p>Osteosarcoma is an aggressive bone tumor that preferentially develops in adolescents. The tu...
<div><p>Osteosarcoma (OS), a bone tumor, exhibit a complex karyotype. On the genomic level a highly ...
Osteosarcoma (OS) is the most common primary malignant tumor of bone, showing complex chromosomal re...
Osteosarcoma (OS), a bone tumor, exhibit a complex karyotype. On the genomic level a highly variable...
Osteosarcoma is a rare but highly malignant cancer of the bone. As a consequence, the number of esta...
Osteosarcomas are the most common non-haematological primary malignant tumours of bone, and all conv...
Introduction: OS, a common Li-Fraumeni syndrome (LFS)-associated neoplasm, is a common bone malignan...
BACKGROUND Osteosarcoma is a rare but highly malignant cancer of the bone. As a consequence, the nu...
AbstractIdentification of target genes for genetic rearrangements in prostate cancer and the impact ...
Little is known about the genomic alterations underlying osteosarcoma. We performed a genomewide hig...
High-grade osteosarcoma is a tumor with a complex genomic profile, occurring primarily in adolescent...
Osteosarcoma is a primary malignancy of bone that affects children and adults. Here, we present the ...
Osteosarcoma is an aggressive bone tumor that preferentially develops in adolescents. The tumor is c...
BACKGROUND: Osteosarcomas are the most common non-haematological primary malignant tumours of bone, ...
. These authors contributed equally to this work. Osteosarcoma is an aggressive bone tumor that pref...
<div><p>Osteosarcoma is an aggressive bone tumor that preferentially develops in adolescents. The tu...
<div><p>Osteosarcoma (OS), a bone tumor, exhibit a complex karyotype. On the genomic level a highly ...
Osteosarcoma (OS) is the most common primary malignant tumor of bone, showing complex chromosomal re...
Osteosarcoma (OS), a bone tumor, exhibit a complex karyotype. On the genomic level a highly variable...
Osteosarcoma is a rare but highly malignant cancer of the bone. As a consequence, the number of esta...
Osteosarcomas are the most common non-haematological primary malignant tumours of bone, and all conv...
Introduction: OS, a common Li-Fraumeni syndrome (LFS)-associated neoplasm, is a common bone malignan...
BACKGROUND Osteosarcoma is a rare but highly malignant cancer of the bone. As a consequence, the nu...
AbstractIdentification of target genes for genetic rearrangements in prostate cancer and the impact ...